It is a pharma private limited company based in Delhi, Delhi, India, established in 2014.
2014 | Delhi, Delhi, India | ActiveSynthokind Pharmaceuticals Private Limited, a active private limited company, was established on 01 February 2014 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909DL2014PTC264328. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Veena Mittal (Director), Amit Mittal (Additional Director). Past directors included Veena Mittal, Amardeep Bansal, Vishav Deep Bansal. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at House No.488, 02Nd Floor, Near Rana Public School, Shahbad Daulatp, Ur, Delhi, Delhi, 110042.
U51909DL2014PTC264328
264328
01 February 2014
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Synthokind Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Veena Mittal | Director | 12 Jan 2017 | Current |
| Amit Mittal | Additional Director | 26 Mar 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
| Pramod Abcsdd | Director | 12 Apr 2014 | Past |
| Pramod Abcsdd | Director | 09 Jul 2018 | Past |
| Pramod Abcsdd | Director | 23 Jan 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Synthokind Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.35% decrease. The company also saw a substantial fall in profitability, with a 24.44% decrease in profit. The company's net worth Soared by an impressive increase of 32.56%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Synthokind Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Synthokind Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Synthokind Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synthokind Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Synthokind Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
The activity Synthokind Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was completed.
Progress on Amit Mittal was appointed as a Additional Director was appointed as a Additional Director on 26 Mar 2018 & has been associated with this company since 7 years 8 months . was documented.
Veena Mittal was appointed as a Director was appointed as a Director on 12 Jan 2017 & has been associated with this company since 8 years 10 months . was recorded as a recent event.
Synthokind Pharmaceuticals Private Limited was registered on 01 Feb 2014 with Roc Delhi & aged 11 years 9 months as per MCA records. was recorded as a recent event.
The CIN of Synthokind Pharmaceuticals Private Limited is U51909DL2014PTC264328.
Synthokind Pharmaceuticals Private Limited is headquartered at House No.488, 02Nd Floor, Near Rana Public School, Shahbad Daulatp, Ur, Delhi, Delhi, 110042.
Synthokind Pharmaceuticals Private Limited was incorporated on 01 February 2014.
The current directors of Synthokind Pharmaceuticals Private Limited are
The primary industry of Synthokind Pharmaceuticals Private Limited is Trade.
Synthokind Pharmaceuticals Private Limited is unlisted.
The authorized capital of Synthokind Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Synthokind Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX